These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 11484070)

  • 21. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
    Walker M; Mari A; Jayapaul MK; Bennett SM; Ferrannini E
    Diabetologia; 2005 Dec; 48(12):2470-6. PubMed ID: 16261308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of insulin measurement in subjects with impaired glucose tolerance or type 2 diabetes].
    Tanaka Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():361-5. PubMed ID: 15779404
    [No Abstract]   [Full Text] [Related]  

  • 23. The pathophysiologic defects of type 2 diabetes. Abnormal insulin action and impaired insulin secretion.
    Kahn SE
    Postgrad Med; 2000 May; 107(6 Suppl Key):11-5. PubMed ID: 19667505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM
    Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of metabolic syndrome on insulin sensitivity, glucose sensitivity, and acute insulin response after glucose load in early-onset type 2 diabetes mellitus: Taiwan Early-Onset Type 2 Diabetes Cohort Study.
    Hsieh CH; Wu CZ; Hsiao FC; Lin JD; Li JC; Wan HL; Kuo SW; Hung YJ; Su CC; Pei D;
    Metabolism; 2008 Nov; 57(11):1615-21. PubMed ID: 18940402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term repeatability of measures of early insulin secretion derived from an intravenous glucose tolerance test and conversion from impaired glucose tolerance to diabetes.
    Laaksonen DE; Niskanen L; Mykkänen H; Juntunen KS; Schwab U; Kolehmainen M; Rauramaa R; Tuomilehto J; Uusitupa M
    Ann Med; 2008; 40(4):303-11. PubMed ID: 18428023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massive weight loss does not restore normal insulin secretory pulses in obese patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Guichard-Rode S; Charrie A; Penet D; Teboul F; Thivolet C
    Diabetes Metab; 1997 Dec; 23(6):506-10. PubMed ID: 9496556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased insulin sensitivity and decreased insulin secretion in offspring of insulin-sensitive type 2 diabetic patients.
    Matsumoto K; Sakamaki H; Izumino K; Yano M; Ueki Y; Miyake S; Tominaga Y
    Metabolism; 2000 Sep; 49(9):1219-23. PubMed ID: 11016908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sugar-sweetened beverage intake on the development of type 2 diabetes mellitus in subjects with impaired glucose tolerance: the Mihama diabetes prevention study.
    Teshima N; Shimo M; Miyazawa K; Konegawa S; Matsumoto A; Onishi Y; Sasaki R; Suzuki T; Yano Y; Matsumoto K; Yamada T; Gabazza EC; Takei Y; Sumida Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):14-9. PubMed ID: 25994135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
    Abdul-Ghani MA; Tripathy D; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1130-9. PubMed ID: 16644654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early disturbances in insulin secretion in the development of type 2 diabetes mellitus.
    van Haeften TW
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):197-204. PubMed ID: 12431813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.
    Lillioja S; Mott DM; Howard BV; Bennett PH; Yki-Järvinen H; Freymond D; Nyomba BL; Zurlo F; Swinburn B; Bogardus C
    N Engl J Med; 1988 May; 318(19):1217-25. PubMed ID: 3283552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A primary defect in glucose production alone cannot induce glucose intolerance without defects in insulin secretion.
    Mangiafico SP; Lim SH; Neoh S; Massinet H; Joannides CN; Proietto J; Andrikopoulos S; Fam BC
    J Endocrinol; 2011 Sep; 210(3):335-47. PubMed ID: 21700659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function.
    Byrne MM; Sturis J; Sobel RJ; Polonsky KS
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E572-9. PubMed ID: 8928761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.